The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Please provide your email address to receive an email when new articles are posted on . Pregnant women with type 1 diabetes had a lower time below range with the MiniMed 780 system vs. standard of ...

Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.

Spending more time in glucose range could help reduce adverse pregnancy outcomes, but available closed-loop insulin delivery systems are not customized to pregnancy-specific needs. In a randomized ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...

Fully Closed-Loop System Feasibility Study to be presented at Insulet Symposium and in e-Poster during ATTD 2026 Real World Evidence of Settings Optimization in Omnipod 5 Users will also be shared ...

Glass is one of wine’s most entrenched—and least questioned—inputs. Yet it is also one of the industry’s biggest environmental liabilities. Packaging and glass transport alone can account for as much ...